Literature DB >> 35788865

[Are there still indications for open adrenalectomy?]

K Holzer1, D K Bartsch2.   

Abstract

Despite the triumph of minimally invasive techniques in adrenal surgery, the indications for open adrenalectomy are indispensable in the canon of treatment options and must remain part of the repertoire of visceral surgery. Open adrenalectomy is indicated for advanced adrenal carcinoma (ENSAT stage III). In addition to the frequent local infiltration of these carcinomas which makes the en bloc resection of adjacent organs necessary, thromboses in the renal vein or the vena cava or multiple lymph node metastases can also necessitate an open procedure; however, open adrenalectomy is justified and must also be discussed for adrenocortical carcinoma ENSAT stages I-II (tumor size ≤ 5 cm or > 5 cm, NO). Furthermore, highly suspicious large adrenal tumors (6-8 cm, Hounsfield units > 20) without preoperative evidence of malignancy and other adrenal pathologies, such as neuroblastomas, large pheochromocytomas and also schwannomas can be an indication for open adrenalectomy.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Adrenal adenoma; Adrenocortical carcinoma; Conversion; ENSAT stages; Neuroblastoma; Pheochromocytoma

Mesh:

Year:  2022        PMID: 35788865     DOI: 10.1007/s00104-022-01678-9

Source DB:  PubMed          Journal:  Chirurgie (Heidelb)        ISSN: 2731-6971


  4 in total

1.  European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma.

Authors:  S Gaujoux; R Mihai
Journal:  Br J Surg       Date:  2017-03       Impact factor: 6.939

2.  Two giant retroperitoneal schwannomas mimicking adrenal malignancy - a case report.

Authors:  Isabelle Fülber; Katharina Peer; Elisabeth Maurer; Detlef K Bartsch; Jannis Görlach; Joachim Nils Göbel; Marion Roeßler; Katharina Holzer
Journal:  Innov Surg Sci       Date:  2020-08-31

3.  A Modern Assessment of Cancer Risk in Adrenal Incidentalomas: Analysis of 2219 Patients.

Authors:  Bora Kahramangil; Emin Kose; Erick M Remer; Jordan P Reynolds; Robert Stein; Brian Rini; Allan Siperstein; Eren Berber
Journal:  Ann Surg       Date:  2022-01-01       Impact factor: 12.969

4.  Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Manisha H Shah; Whitney S Goldner; Al B Benson; Emily Bergsland; Lawrence S Blaszkowsky; Pamela Brock; Jennifer Chan; Satya Das; Paxton V Dickson; Paul Fanta; Thomas Giordano; Thorvardur R Halfdanarson; Daniel Halperin; Jin He; Anthony Heaney; Martin J Heslin; Fouad Kandeel; Arash Kardan; Sajid A Khan; Boris W Kuvshinoff; Christopher Lieu; Kimberly Miller; Venu G Pillarisetty; Diane Reidy; Sarimar Agosto Salgado; Shagufta Shaheen; Heloisa P Soares; Michael C Soulen; Jonathan R Strosberg; Craig R Sussman; Nikolaos A Trikalinos; Nataliya A Uboha; Namrata Vijayvergia; Terence Wong; Beth Lynn; Cindy Hochstetler
Journal:  J Natl Compr Canc Netw       Date:  2021-07-28       Impact factor: 11.908

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.